187 related articles for article (PubMed ID: 10892716)
41. Polymerase chain reaction analysis of immunoglobulin gene rearrangement in cutaneous lymphoid hyperplasias. French Study Group for Cutaneous Lymphomas.
Bouloc A; Delfau-Larue MH; Lenormand B; Meunier F; Wechsler J; Thomine E; Revuz J; Farcet JP; Joly P; Bagot M
Arch Dermatol; 1999 Feb; 135(2):168-72. PubMed ID: 10052401
[TBL] [Abstract][Full Text] [Related]
42. Distinction between diffuse cutaneous malignant follicular center cell lymphoma and lymphoid hyperplasia by computerized nuclear image analysis.
Spina D; Miracco C; Santopietro R; Sforza V; Leoncini L; Pacenti L; Lio R; Luzi P; Tosi P; Kraft R
Am J Dermatopathol; 1993 Oct; 15(5):415-22. PubMed ID: 8238778
[TBL] [Abstract][Full Text] [Related]
43. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
[TBL] [Abstract][Full Text] [Related]
44. Atypical lymphoid infiltrates arising in cutaneous lesions of connective tissue disease.
Magro CM; Crowson AN; Harrist TJ
Am J Dermatopathol; 1997 Oct; 19(5):446-55. PubMed ID: 9335237
[TBL] [Abstract][Full Text] [Related]
45. Cutaneous lymphoid hyperplasia and reactive lymphadenopathy induced by hepatitis B vaccination.
Atalar H; Sarifakioglu E; Dener C; Yanik B; Koktener A; Bayrak R
Eur J Dermatol; 2008; 18(2):188-9. PubMed ID: 18424381
[No Abstract] [Full Text] [Related]
46. Cutaneous borreliosis associated with T cell-predominant infiltrates: a diagnostic challenge.
Kempf W; Kazakov DV; Hübscher E; Gugerli O; Gerbig AW; Schmid R; Palmedo G; Kutzner H
J Am Acad Dermatol; 2015 Apr; 72(4):683-9. PubMed ID: 25617014
[TBL] [Abstract][Full Text] [Related]
47. Lymphoma- and leukemia-associated cutaneous atypical CD30+ T-cell reactions.
Su LD; Duncan LM
J Cutan Pathol; 2000 May; 27(5):249-54. PubMed ID: 10847550
[TBL] [Abstract][Full Text] [Related]
48. Cutaneous lymphoid hyperplasia. Immunologic characteristics and assessment of criteria recently proposed as diagnostic of malignant lymphoma.
Medeiros LJ; Picker LJ; Abel EA; Hu CH; Hoppe RT; Warnke RA; Wood GS
J Am Acad Dermatol; 1989 Nov; 21(5 Pt 1):929-42. PubMed ID: 2808829
[TBL] [Abstract][Full Text] [Related]
49. Differential diagnosis of cutaneous infiltrates of B lymphocytes with follicular growth pattern.
Leinweber B; Colli C; Chott A; Kerl H; Cerroni L
Am J Dermatopathol; 2004 Feb; 26(1):4-13. PubMed ID: 14726817
[TBL] [Abstract][Full Text] [Related]
50. Gastric "pseudolymphoma": a retrospective morphologic and immunophenotypic study of 97 cases.
Abbondanzo SL; Sobin LH
Cancer; 1997 May; 79(9):1656-63. PubMed ID: 9128979
[TBL] [Abstract][Full Text] [Related]
51. Cefuroxime induced lymphomatoid hypersensitivity reaction.
Saeed SA; Bazza M; Zaman M; Ryatt KS
Postgrad Med J; 2000 Sep; 76(899):577-9. PubMed ID: 10964126
[TBL] [Abstract][Full Text] [Related]
52. Cutaneous lymphoid hyperplasia (pseudolymphoma) in a tattoo after far infrared light.
Chiang C; Romero L
Dermatol Surg; 2009 Sep; 35(9):1434-8. PubMed ID: 19549070
[No Abstract] [Full Text] [Related]
53. Cutaneous pseudolymphomas: inflammatory reactive proliferations.
Hussein MR
Expert Rev Hematol; 2013 Dec; 6(6):713-33. PubMed ID: 24191857
[TBL] [Abstract][Full Text] [Related]
54. Drug-associated lymphoma and pseudolymphoma: recognition and management.
Albrecht J; Fine LA; Piette W
Dermatol Clin; 2007 Apr; 25(2):233-44, vii. PubMed ID: 17430760
[TBL] [Abstract][Full Text] [Related]
55. Drug induced pseudolymphoma.
Magro CM; Daniels BH; Crowson AN
Semin Diagn Pathol; 2018 Jul; 35(4):247-259. PubMed ID: 29361381
[TBL] [Abstract][Full Text] [Related]
56. Clonal rearrangements of immunoglobulin genes and progression to B cell lymphoma in cutaneous lymphoid hyperplasia.
Wood GS; Ngan BY; Tung R; Hoffman TE; Abel EA; Hoppe RT; Warnke RA; Cleary ML; Sklar J
Am J Pathol; 1989 Jul; 135(1):13-9. PubMed ID: 2774056
[TBL] [Abstract][Full Text] [Related]
57. Lymphomatoid granulomatosis of the skin and lung. An angiocentric T-cell-rich B-cell lymphoproliferative disorder.
McNiff JM; Cooper D; Howe G; Crotty PL; Tallini G; Crouch J; Eisen RN
Arch Dermatol; 1996 Dec; 132(12):1464-70. PubMed ID: 8961876
[TBL] [Abstract][Full Text] [Related]
58. Cutaneous Pseudolymphoma With Langerhans Cell Hyperplasia-A Rare Case With Clinical Presentation Mimicking Malignancy and Potential Diagnostic Pitfall.
Ye CH; Chen CJ; Chang KC; Wu YH; Chen ML; Chiu TM
Am J Dermatopathol; 2021 Dec; 43(12):e280-e284. PubMed ID: 34001745
[TBL] [Abstract][Full Text] [Related]
59. [Cutaneous pseudolymphomas and pseudoclonality of lymphoid infiltrates].
Quatresooz P; Piérard-Franchimont C; Devillers C; Piérard GE
Rev Med Liege; 2009 Nov; 64(11):581-6. PubMed ID: 20069973
[TBL] [Abstract][Full Text] [Related]
60. CD30 Positive Lymphomatoid Angiocentric Drug Reactions: Characterization of a Series of 20 Cases.
Magro CM; Olson LC; Nguyen GH; de Feraudy SM
Am J Dermatopathol; 2017 Jul; 39(7):508-517. PubMed ID: 27655118
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
